BACKGROUND: HNF1A-MODY (MODY3) is a common subtype of autosomal dominant diabetes. Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, history of transient insulin overproduction has not yet been recognized in individuals with HNF1A-MODY. CASE REPORT: Here, we report on a 40-year-old male patient with HNF1A mutation p.Arg272His (c.815G>A) having a history of fetal macrosomia (4750 g, 59 cm), and, at least, one attack of symptomatic hypoglycemia in childhood. Diabetes was subsequently diagnosed at 19 years of age. The proband's daughter who developed diabetes at 16 years carries the same mutation, but her birth weight and length were in the upper normal range, and she never experienced hypoglycemic symptoms. CONCLUSION: The observation of fetal macrosomia and hypoglycemia in childhood is indicative of a biphasic impact of the HNF1A mutation on p-cell function over the lifespan, leading from inappropriate insulin oversecretion to final clinical diabetes.
BACKGROUND:HNF1A-MODY (MODY3) is a common subtype of autosomal dominant diabetes. Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, history of transient insulin overproduction has not yet been recognized in individuals with HNF1A-MODY. CASE REPORT: Here, we report on a 40-year-old male patient with HNF1A mutation p.Arg272His (c.815G>A) having a history of fetal macrosomia (4750 g, 59 cm), and, at least, one attack of symptomatic hypoglycemia in childhood. Diabetes was subsequently diagnosed at 19 years of age. The proband's daughter who developed diabetes at 16 years carries the same mutation, but her birth weight and length were in the upper normal range, and she never experienced hypoglycemic symptoms. CONCLUSION: The observation of fetal macrosomia and hypoglycemia in childhood is indicative of a biphasic impact of the HNF1A mutation on p-cell function over the lifespan, leading from inappropriate insulin oversecretion to final clinical diabetes.
Authors: Kara E Boodhansingh; Zhongying Yang; Changhong Li; Pan Chen; Katherine Lord; Susan A Becker; Lisa J States; N Scott Adzick; Tricia Bhatti; Show-Ling Shyng; Arupa Ganguly; Charles A Stanley; Diva D De Leon Journal: Eur J Endocrinol Date: 2022-06-27 Impact factor: 6.558
Authors: Ehm A Andersson; Marie N Harder; Kasper Pilgaard; Charlotta Pisinger; Alena Stančáková; Johanna Kuusisto; Niels Grarup; Kristine Færch; Pernille Poulsen; Daniel R Witte; Torben Jørgensen; Allan Vaag; Markku Laakso; Oluf Pedersen; Torben Hansen Journal: PLoS One Date: 2011-11-04 Impact factor: 3.240
Authors: Kara E Boodhansingh; Balamurugan Kandasamy; Lauren Mitteer; Stephanie Givler; Diva D De Leon; Show-Ling Shyng; Arupa Ganguly; Charles A Stanley Journal: Am J Med Genet A Date: 2019-08-28 Impact factor: 2.802
Authors: Sara Jane Cromer; Aluma Chovel Sella; Emily Rosenberg; Kevin Scully; Marie McDonnell; Ana Paula Abreu; Michelle Weil; Sarah N Bernstein; Maryanne Quinn; Camille Powe; Deborah M Mitchell; Miriam S Udler Journal: AACE Clin Case Rep Date: 2022-08-08